Literature DB >> 23054002

R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Abdolkarim Mahrooz1, Ghorban Gohari, Mohammad-Bagher Hashemi, Mehryar Zargari, Hadis Musavi, Mahmoud Abedini, Ahad Alizadeh.   

Abstract

The polymorphic gene of serum paraoxonase (PON1) and its activity involved in atherosclerosis. The purpose of the study was to analyze PON1 192 Q/R polymorphism and the enzyme activities in ischemic stroke. The polymorphism as the most common polymorphism in PON1 gene coding sequence is associated with variation in the enzyme activity and vascular disease. The study included 85 stroke patients and 71 control subjects. PON1 192 polymorphism was genotyped using PCR protocol. Paraoxonase activity (Para) and arylesterase activity (Aryl) were determined spectrophotometrically using paraoxon and phenylacetate as the substrates. The QR and RR genotypes were more frequent in stroke population compared to controls, resulting in a higher frequency of the R allele in patients (0.24 vs 0.18, OR = 1.41). Patients had significantly higher Para/Aryl ratio than that of controls (P = 0.016). In stroke patients, Para/Aryl and Para/HDL ratios increased with this order: QQ < QR < RR. Hypertension significantly increased the risk of ischemic stroke by 15-fold among R-containing people, while this was significantly increased 4-fold for QQ homozygotes. Smoking increased the risk of having ischemic stroke in both QQ homozygote and QR + RR group (OR = 2.84 and OR = 2.33, respectively). In conclusion, these data highlight the importance of PON1 192 R allele and high Para/Aryl ratio in susceptibility to ischemic stroke in the population. The presence of the 192 R allele potentiates the risk of stroke especially in hypertensive people. Decreased Aryl and increased Para/Aryl, Para/HDL and Aryl/HDL ratios may be markers indicated the increased susceptibility to ischemic stroke in the population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054002     DOI: 10.1007/s11033-012-2027-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  38 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

3.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

Review 4.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

5.  The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.

Authors:  D Ombres; G Pannitteri; A Montali; A Candeloro; F Seccareccia; F Campagna; R Cantini; P P Campa; G Ricci; M Arca
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

6.  Determinants of variation in human serum paraoxonase activity.

Authors:  D L Rainwater; S Rutherford; T D Dyer; E D Rainwater; S A Cole; J L Vandeberg; L Almasy; J Blangero; J W Maccluer; M C Mahaney
Journal:  Heredity (Edinb)       Date:  2008-10-29       Impact factor: 3.821

7.  Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.

Authors:  Larry Baum; Ho Keung Ng; Kam Sang Woo; Brian Tomlinson; Timothy Hudson Rainer; Xiangyan Chen; Wing Sze Cheung; Daniel Kam Yin Chan; G Neil Thomas; Cindy See Wai Tong; Ka Sing Wong
Journal:  Clin Biochem       Date:  2006-02-09       Impact factor: 3.281

Review 8.  Paraoxonase: a multifaceted biomolecule.

Authors:  Binita Goswami; Devika Tayal; Nikhil Gupta; V Mallika
Journal:  Clin Chim Acta       Date:  2009-09-30       Impact factor: 3.786

9.  Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.

Authors:  No Soo Kim; Kyungwon Kang; Min Ho Cha; Bong-Joo Kang; Jinseok Moon; Byoung Kab Kang; Byeong-Chan Yu; Yoon-Sik Kim; Sun Mi Choi; Ok-Sun Bang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-04       Impact factor: 3.575

10.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

View more
  9 in total

Review 1.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

2.  Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.

Authors:  Chiara Cristina Bortolasci; Heber Odebrecht Vargas; André Souza-Nogueira; Estefania Gastaldello Moreira; Sandra Odebrecht Vargas Nunes; Michael Berk; Seetal Dodd; Décio Sabbatini Barbosa; Michael Maes
Journal:  Redox Rep       Date:  2014-07-18       Impact factor: 4.412

3.  The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.

Authors:  Mehryar Zargari; Fahimeh Sharafeddin; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

Review 4.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

5.  Paraoxonase-1 (PON1) rs662 Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Zhuang Population.

Authors:  You Li; Guiyun Liang; Liwei Shi; Xue Liang; Bingshuang Long; Jian Qin; Zhiyong Zhang
Journal:  Med Sci Monit       Date:  2016-12-27

6.  Proteomics-Based Approach to Identify Novel Blood Biomarker Candidates for Differentiating Intracerebral Hemorrhage From Ischemic Stroke-A Pilot Study.

Authors:  David Malicek; Ilka Wittig; Sebastian Luger; Christian Foerch
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

7.  Grape polyphenols increase the activity of HDL enzymes in old and obese rats.

Authors:  Andriy L Zagayko; Ganna B Kravchenko; Oksana A Krasilnikova; Yuri O Ogai
Journal:  Oxid Med Cell Longev       Date:  2013-07-14       Impact factor: 6.543

8.  Joint Effects of PON1 Polymorphisms and Vegetable Intake on Ischemic Stroke: A Family-Based Case Control Study.

Authors:  Juan Juan; Xia Jiang; Xun Tang; Yiqun Wu; Kexin Sun; Xiao Xiang; Yaohua Tian; Tao Wu; Qi Sun; Peter Kraft; Yonghua Hu
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

9.  Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.

Authors:  Durdi Qujeq; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi; Saleh Annemohammadzadeh; Ruzbeh Boorank
Journal:  J Diabetes Metab Disord       Date:  2018-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.